530 related articles for article (PubMed ID: 16442398)
21. Atherogenesis: why women live longer than men.
Hazzard WR
Geriatrics; 1985 Jan; 40(1):42-51, 54. PubMed ID: 3965355
[TBL] [Abstract][Full Text] [Related]
22. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
[TBL] [Abstract][Full Text] [Related]
23. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
Cooke CE; Hammerash WJ
Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
[TBL] [Abstract][Full Text] [Related]
24. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.
Grover SA; Lowensteyn I; Joseph L; Kaouache M; Marchand S; Coupal L; Boudreau G;
Arch Intern Med; 2007 Nov; 167(21):2296-303. PubMed ID: 18039987
[TBL] [Abstract][Full Text] [Related]
25. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
[TBL] [Abstract][Full Text] [Related]
26. Gender differences in the lipid profile of dyslipidemic subjects.
Kolovou GD; Anagnostopoulou KK; Damaskos DS; Bilianou HI; Mihas C; Milionis HJ; Kostakou PM; Cokkinos DV
Eur J Intern Med; 2009 Mar; 20(2):145-51. PubMed ID: 19327602
[TBL] [Abstract][Full Text] [Related]
27. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data.
Kronmal RA; Cain KC; Ye Z; Omenn GS
Arch Intern Med; 1993 May; 153(9):1065-73. PubMed ID: 8481074
[TBL] [Abstract][Full Text] [Related]
28. Cholesterol and coronary events. The current thinking.
Jones PH
Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618
[TBL] [Abstract][Full Text] [Related]
29. Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).
Shlipak MG; Chaput LA; Vittinghoff E; Lin F; Bittner V; Knopp RH; Hulley SB;
Am Heart J; 2003 Nov; 146(5):870-5. PubMed ID: 14597937
[TBL] [Abstract][Full Text] [Related]
30. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
Pool JL; Lenz ML; Taylor AA
J Hum Hypertens; 1990 Oct; 4 Suppl 3():23-33. PubMed ID: 1979819
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
32. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
Tóth PP; Potter D; Ming EE
J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
[TBL] [Abstract][Full Text] [Related]
34. Lipoproteins and cardiovascular risk--from genetics to CHD prevention.
Cullen P; Funke H; Schulte H; Assmann G
Eur Heart J; 1998 Apr; 19 Suppl C():C5-11. PubMed ID: 9597420
[TBL] [Abstract][Full Text] [Related]
35. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios.
Kinosian B; Glick H; Preiss L; Puder KL
J Investig Med; 1995 Oct; 43(5):443-50. PubMed ID: 8528755
[TBL] [Abstract][Full Text] [Related]
36. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.
Weverling-Rijnsburger AW; Jonkers IJ; van Exel E; Gussekloo J; Westendorp RG
Arch Intern Med; 2003 Jul; 163(13):1549-54. PubMed ID: 12860577
[TBL] [Abstract][Full Text] [Related]
37. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
[TBL] [Abstract][Full Text] [Related]
38. Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey.
Ansell BJ; Fonarow GC; Maki KC; Dicklin MR; Bell M; Davidson MH;
Am Heart J; 2006 Nov; 152(5):976-81. PubMed ID: 17070174
[TBL] [Abstract][Full Text] [Related]
39. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.
Odenigbo CU; Oguejiofor OC; Odenigbo UM; Ibeh CC; Ajaero CN; Odike MA
Niger J Clin Pract; 2008 Dec; 11(4):330-5. PubMed ID: 19320405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]